Objectives: This study sought to review the literature for risk prediction models in patients with heart failure and to identify the most consistently reported independent predictors of risk across models. Background: Risk assessment provides information about patient prognosis, guides decision making about the type and intensity of care, and enables better understanding of provider performance. Methods: MEDLINE and EMBASE were searched from January 1995 to March 2013, followed by hand searches of the retrieved reference lists. Studies were eligible if they reported at least 1 multivariable model for risk prediction of death, hospitalization, or both in patients with heart failure and reported model performance. We ranked rep...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...
Importance: The clinical practice guidelines for heart failure recommend the use of validated risk m...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...
Objectives: This study sought to review the literature for risk prediction models in patients wit...
Objectives: This study sought to review the literature for risk prediction models in patients with h...
OBJECTIVES: This study sought to review the literature for risk prediction models in patients with h...
OBJECTIVES: This study sought to review the literature for risk prediction models in patients with h...
Objectives This study sought to review the literature for risk prediction models in patients with he...
BACKGROUND:The ability to predict risk allows healthcare providers to propose which patients might b...
The present paper systematically reviews and compares existing prediction models in order to establi...
The present paper systematically reviews and compares existing prediction models in order to establi...
Refer to the page 659-667 Heart failure (HF) is a common clinical syndrome with high mor-bidity and ...
AIMS: We aimed to develop prognostic models for patients with chronic heart failure (CHF). METHODS A...
Introduction: From a prospective multicentre multicountry clinical trial, we developed and valid...
Introduction: From a prospective multi-center multi-country clinical trial, we developed and validat...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...
Importance: The clinical practice guidelines for heart failure recommend the use of validated risk m...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...
Objectives: This study sought to review the literature for risk prediction models in patients wit...
Objectives: This study sought to review the literature for risk prediction models in patients with h...
OBJECTIVES: This study sought to review the literature for risk prediction models in patients with h...
OBJECTIVES: This study sought to review the literature for risk prediction models in patients with h...
Objectives This study sought to review the literature for risk prediction models in patients with he...
BACKGROUND:The ability to predict risk allows healthcare providers to propose which patients might b...
The present paper systematically reviews and compares existing prediction models in order to establi...
The present paper systematically reviews and compares existing prediction models in order to establi...
Refer to the page 659-667 Heart failure (HF) is a common clinical syndrome with high mor-bidity and ...
AIMS: We aimed to develop prognostic models for patients with chronic heart failure (CHF). METHODS A...
Introduction: From a prospective multicentre multicountry clinical trial, we developed and valid...
Introduction: From a prospective multi-center multi-country clinical trial, we developed and validat...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...
Importance: The clinical practice guidelines for heart failure recommend the use of validated risk m...
INTRODUCTION: From a prospective multicentre multicountry clinical trial, we developed and validated...